Investor FAQs

Expand All
The Company’s headquarters are located at 75 Hayden Ave, Lexington, MA 02421. The main office number is 857-259-5340.
The Voyager Therapeutics ticker is VYGR and it is traded on the NASDAQ Global Select Market.
November 11, 2015
You can view our Board of Directors by visiting https://www.voyagertherapeutics.com/about-us/.
You can view our leadership team by visiting https://www.voyagertherapeutics.com/about-us/.
The Company’s fiscal year ends on December 31st.
Our Legal Counsel: Wilmer Cutler Pickering Hale and Dorr LLP, 7 World Trade Center, 250 Greenwich Street, New York, NY 10007, (212) 937-7518
Our Auditors: Ernst & Young, LLP, 200 Clarendon St, Boston, MA 02116, (617) 266-2000
Our transfer agent is:

Computershare Trust N.A.
P.O. Box 43078
Providence, RI 02940
1-800-942-5909
Voyager does not currently, nor do we expect to, declare or pay any cash or other dividends on our common stock in the foreseeable future.
Voyager does not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information section of our Investors & Media webpage or directly from the SEC at www.sec.gov.
You can reach Investor Relations by emailing investors@voyagertherapeutics.com.